The conference programme will be built around 9 Sessions:
- Enabling Chemistries for Chemical Biology Research
Chair: Prof. Daniel Harki, University of Minnesota, US
- Advances in Targeted Protein Degradation
Chair: Prof. Terry Moore, University of Illinois, US
- A Focus on Early Career Investigators
Chair: Dr Melissa Grenier-Davies, GlaxoSmithKline, US
- Chemical Modulation of RNA
Chair: Dr Darby Schmidt, Sonata Therapeutics, US
- Computational Approaches to Identify and Target Cryptic and Allosteric Pockets
Chair: Dr Malin Lemurell, AstraZeneca, SE
- Drug Targets in GPCR Signalling
Chair: Prof. György Keseru, Research Centre for Natural Sciences (RCNS), HU
- Getting Out of the Starting Block: New Hit Finding and Chemotype Advancement Methods
Chair: Dr Carolyn Dzierba, BMS, US
- Organic Synthesis Impacting Medicinal Chemistry & Chemical Biology
Chair: Prof. Rui Moreira, University of Lisbon, PT
- Proximity-inducing Molecules and their Therapeutic Applications
Chair: Dr Amit Choudhary, Broad Institute, US